WARSAW, Poland, September 22, 2016 /PRNewswire/ --
Worldwide Clinical Trials (http://www.worldwide.com), one of the world's leading, full-service contract research organizations (CROs), has opened a new office in the heart of Warsaw's central business district. Home to 30+ employees, the 315m2 office space in the Prosta Tower boasts state-of-the-art technology and design, supporting a collaborative, productive work environment.
"At Worldwide, we offer inspiring and engaging work environments for our hard-working team members around the globe, which is why we chose Warsaw's prestigious Prosta Tower building for our new office," explains Peter Benton, President and Chief Operating Officer at Worldwide Clinical Trials, who visited the new offices this week to congratulate employees on their new space. "As Worldwide continues to grow, it's important for us to create attractive spaces for our employees."
The move demonstrates Worldwide's commitment to improving workspaces, as the new office features an abundance of light, open working areas, and collaborative meeting spaces for its Warsaw-based employees, who work in a variety of roles including clinical operations and administrative services. Having operated successfully in Warsaw since 2008, the new office also shows Worldwide's continued investment in the region and in its global operations.
Connect with Worldwide Clinical Trials:
- Tweet: @worldwidetrials opens modern, collaborative office in Warsaw's central business district
- Follow us on Twitter: @worldwidetrials
- Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.worldwide.com.
SOURCE Worldwide Clinical Trials